SEC Filings for Northwest Biotherapeutics Inc. (NWBO)

$ 0.25 0.00 (0.00%) Volume: 159.73k 10:54 AM EDT Sep 19, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QQuarterly report with a continuing view of a company's financial position3308/09/2019
8-KReport of unscheduled material events or corporate changes.307/22/2019
424B5Prospectus filed under Rule 424(b)(5)3907/18/2019
424B5Prospectus filed under Rule 424(b)(5)3907/17/2019
8-KReport of unscheduled material events or corporate changes.405/28/2019
10-QQuarterly report with a continuing view of a company's financial position3005/10/2019
10-KAnnual report with a comprehensive overview of the company22804/02/2019
NT 10-KNotification that form 10-K will be submitted late203/19/2019
SC 13G/AAmendment to the SC 13G filing602/14/2019
SC 13G/AAmendment to the SC 13G filing802/14/2019
8-KReport of unscheduled material events or corporate changes.302/07/2019
4Statement of changes in beneficial ownership of securities101/29/2019
DEF 14AOfficial notification to shareholders of matters to be brought to a vote (Proxy)2701/08/2019
8-KReport of unscheduled material events or corporate changes.312/20/2018
8-KReport of unscheduled material events or corporate changes.512/11/2018
<<
First
<
Prev
123456789101112131415